Skip to content
Psychiatry

Publications (vanha)

2026

Search PubMed

2025

Search PubMed

2024

  1. Ahti, J, Kieseppä, T, Haaki, W, Suvisaari, J, Niemelä, S, Suokas, K et al.. General medical comorbidities in psychotic disorders in the Finnish SUPER study. Schizophrenia (Heidelb). 2024;10 (1):124. doi: 10.1038/s41537-024-00546-1. PubMed PMID:39741144 PubMed Central PMC11688420.
  2. Gonçalves, MM, Lutz, W, Schwartz, B, Oliveira, JT, Saarni, SE, Tishby, O et al.. Developing a European Psychotherapy Consortium (EPoC): Towards Adopting a Single-Item Self-Report Outcome Measure Across European Countries. Clin Psychol Eur. 2024;6 (3):e13827. doi: 10.32872/cpe.13827. PubMed PMID:39678318 PubMed Central PMC11636744.
  3. Tavast, IM, Solismaa, A, Lyytikäinen, LP, Mononen, N, Moilanen, E, Hämäläinen, M et al.. Leptin and leptin receptor gene polymorphisms and depression treatment response. Acta Neuropsychiatr. 2024;37 :e38. doi: 10.1017/neu.2024.43. PubMed PMID:39529327 PubMed Central PMC13130323.
  4. Partanen, JJ, Häppölä, P, Kämpe, A, Ahola-Olli, A, Hellsten, A, Rask, SM et al.. High Burden of Ileus and Pneumonia in Clozapine-Treated Individuals With Schizophrenia: A Finnish 25-Year Follow-Up Register Study. Am J Psychiatry. 2024;181 (10):879-892. doi: 10.1176/appi.ajp.20230744. PubMed PMID:39262212 .
  5. Mikkonen, K, Helminen, EE, Saarni, SI, Saarni, SE. Learning Outcomes of e-Learning in Psychotherapy Training and Comparison With Conventional Training Methods: Systematic Review. J Med Internet Res. 2024;26 :e54473. doi: 10.2196/54473. PubMed PMID:39073862 PubMed Central PMC11319893.
  6. Savander, EÉ, Voutilainen, L, Hintikka, J, Peräkylä, A. What to take up from the patient’s talk? The clinician’s responses to the patient’s self-disclosure of their subjective experience in the psychiatric intake interview. Front Psychiatry. 2024;15 :1352601. doi: 10.3389/fpsyt.2024.1352601. PubMed PMID:38974916 PubMed Central PMC11224953.
  7. Valtonen, P, Markkanen, S, Järventausta, K, Tenhunen, M, Kalliomäki, ML. In response to “Nitrous oxide inhalation: History and experiences,” a letter to the Editor by Kroneberg et al. Acta Anaesthesiol Scand. 2024;68 (8):1130-1131. doi: 10.1111/aas.14469. PubMed PMID:38923524 .
  8. Sandström, K, Kampman, O, Asellus, P. A retrospective analysis of iv ketamine outcome on hospitalisations in an unselected psychiatric sample. Acta Neuropsychiatr. 2024;37 :e13. doi: 10.1017/neu.2024.18. PubMed PMID:38659205 PubMed Central PMC13130326.
  9. Puolakka, H, Solismaa, A, Lyytikäinen, LP, Viikki, M, Seppälä, N, Mononen, N et al.. Polymorphisms in and associated with dry mouth in clozapine-treated patients. Acta Neuropsychiatr. 2024;36 (4):218-223. doi: 10.1017/neu.2024.9. PubMed PMID:38634369 .
  10. Valtonen, P, Markkanen, S, Järventausta, K, Tenhunen, M, Kalliomäki, ML. More than just joy: A qualitative analysis of participant experiences during nitrous oxide sedation. Acta Anaesthesiol Scand. 2024;68 (7):906-912. doi: 10.1111/aas.14428. PubMed PMID:38594960 .
  11. Cederlöf, E, Holm, M, Taipale, H, Tiihonen, J, Tanskanen, A, Lähteenvuo, M et al.. Antipsychotic medications and sleep problems in patients with schizophrenia. Schizophr Res. 2024;267 :230-238. doi: 10.1016/j.schres.2024.03.015. PubMed PMID:38579432 .
  12. Kämpe, A, Suvisaari, J, Lähteenvuo, M, Singh, T, Ahola-Olli, A, Urpa, L et al.. Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders. Mol Psychiatry. 2024;29 (9):2733-2741. doi: 10.1038/s41380-024-02516-6. PubMed PMID:38556557 PubMed Central PMC11420086.
  13. Denissoff, A, Taipale, H, Tiihonen, J, Di Forti, M, Mittendorfer-Rutz, E, Tanskanen, A et al.. Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study. Schizophr Bull. 2024;50 (6):1287-1294. doi: 10.1093/schbul/sbae034. PubMed PMID:38534050 PubMed Central PMC11578669.
  14. Mäkipelto, V, Tuulio-Henriksson, A, Hakulinen, C, Niemelä, S, Lähteenvuo, M, Wegelius, A et al.. Association of antidepressant and benzodiazepine use, and anticholinergic burden with cognitive performance in schizophrenia. Schizophr Res. 2024;266 :118-126. doi: 10.1016/j.schres.2024.02.025. PubMed PMID:38401410 .
  15. Levola, J, Alakokkare, AE, Denissoff, A, Mustonen, A, Miettunen, J, Niemelä, S et al.. Adolescent alcohol and cannabis use and early adulthood educational attainment in the 1986 Northern Finland birth cohort study. BMC Public Health. 2024;24 (1):255. doi: 10.1186/s12889-024-17693-w. PubMed PMID:38254063 PubMed Central PMC10804574.
  16. Salminen, SP, Solismaa, A, Lyytikäinen, LP, Paavonen, V, Mononen, N, Lehtimäki, T et al.. Genetic risk scores associated with temperament clusters in Finnish depression patients. Acta Neuropsychiatr. 2024;36 (1):51-59. doi: 10.1017/neu.2023.33. PubMed PMID:37665031 .
  17. Leppänen, H, Kampman, O, Autio, R, Karolaakso, T, Rissanen, P, Näppilä, T et al.. Socioeconomic status, psychotherapy duration, and return to work from disability due to common mental disorders. Psychother Res. 2024;34 (5):694-707. doi: 10.1080/10503307.2023.2229500. PubMed PMID:37399567 .
  18. Suokas, K, Kurkela, O, Nevalainen, J, Suvisaari, J, Hakulinen, C, Kampman, O et al.. Geographical variation in treated psychotic and other mental disorders in Finland by region and urbanicity. Soc Psychiatry Psychiatr Epidemiol. 2024;59 (1):37-49. doi: 10.1007/s00127-023-02516-x. PubMed PMID:37308692 PubMed Central PMC10799825.

Search PubMed